Published in Cell Growth Differ on August 01, 1993
Incomplete penetrance of familial retinoblastoma linked to germ-line mutations that result in partial loss of RB function. Proc Natl Acad Sci U S A (1997) 1.21
Enhanced tumor cell growth suppression by an N-terminal truncated retinoblastoma protein. Proc Natl Acad Sci U S A (1994) 1.08
Temperature-sensitive RB mutations linked to incomplete penetrance of familial retinoblastoma in 12 families. Am J Hum Genet (1999) 0.92
Further characterization of retinoblastoma gene-mediated cell growth and tumor suppression in human cancer cells. Proc Natl Acad Sci U S A (1994) 0.86
A chemical switch for inhibitor-sensitive alleles of any protein kinase. Nature (2000) 10.16
Rat galactose-1-phosphate uridyltransferase coding sequence, transcription start site and genomic organization. DNA Seq (1993) 9.01
Genetic enhancement of learning and memory in mice. Nature (1999) 8.06
Levels of gamma-glutamyltranspeptidase in cultured skin fibroblasts from cystinotics and normals. Life Sci (1980) 7.31
Identification of cellular proteins that can interact specifically with the T/E1A-binding region of the retinoblastoma gene product. Cell (1991) 6.55
Abnormalities in structure and expression of the human retinoblastoma gene in SCLC. Science (1988) 4.26
Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumor cells. Proc Natl Acad Sci U S A (1990) 4.06
Enrichment induces structural changes and recovery from nonspatial memory deficits in CA1 NMDAR1-knockout mice. Nat Neurosci (2000) 4.01
Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease. Neurology (2007) 3.97
Is combined spinal-epidural analgesia associated with more rapid cervical dilation in nulliparous patients when compared with conventional epidural analgesia? Anesthesiology (1999) 3.45
Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas. Cancer Res (1997) 3.17
jun-B inhibits and c-fos stimulates the transforming and trans-activating activities of c-jun. Cell (1989) 3.05
Stable binding to E2F is not required for the retinoblastoma protein to activate transcription, promote differentiation, and suppress tumor cell growth. Genes Dev (1998) 3.01
Longitudinal CSF and MRI biomarkers improve the diagnosis of mild cognitive impairment. Neurobiol Aging (2005) 3.00
p53: a transdominant regulator of transcription whose function is ablated by mutations occurring in human cancer. EMBO J (1992) 2.90
Pain management and chemical dependency. Evolving perspectives. JAMA (1997) 2.89
Aberrant promoter methylation of multiple genes in non-small cell lung cancers. Cancer Res (2001) 2.80
Expression of a transfected human c-myc oncogene inhibits differentiation of a mouse erythroleukaemia cell line. Nature (1986) 2.57
Abrogation of metastatic properties of tumour cells by de novo expression of H-2K antigens following H-2 gene transfection. Nature (1985) 2.48
A single amino acid substitution results in a retinoblastoma protein defective in phosphorylation and oncoprotein binding. Proc Natl Acad Sci U S A (1990) 2.46
A pilot trial of G3139, a bcl-2 antisense oligonucleotide, and paclitaxel in patients with chemorefractory small-cell lung cancer. Ann Oncol (2002) 2.42
Invasiveness and metastasis of NIH 3T3 cells induced by Met-hepatocyte growth factor/scatter factor autocrine stimulation. Proc Natl Acad Sci U S A (1994) 2.36
Structural basis for selective inhibition of Src family kinases by PP1. Chem Biol (1999) 2.35
Ductal epithelial proliferations of the breast: a biological continuum? Comparative genomic hybridization and high-molecular-weight cytokeratin expression patterns. J Pathol (2001) 2.33
The Carolina Breast Cancer Study: integrating population-based epidemiology and molecular biology. Breast Cancer Res Treat (1995) 2.31
Inhibition of cyclin D-CDK4/CDK6 activity is associated with an E2F-mediated induction of cyclin kinase inhibitor activity. Proc Natl Acad Sci U S A (1996) 2.30
Prevalence and specificity of LKB1 genetic alterations in lung cancers. Oncogene (2007) 2.27
CDKN2 gene silencing in lung cancer by DNA hypermethylation and kinetics of p16INK4 protein induction by 5-aza 2'deoxycytidine. Oncogene (1995) 2.23
Inactivation of the p16 (INK4A) tumor-suppressor gene in pancreatic duct lesions: loss of intranuclear expression. Cancer Res (1998) 2.23
Incidence of epidural catheter replacement in parturients: a retrospective chart review. Int J Obstet Anesth (1998) 2.22
Multicentre prospective phase II trial of gefitinib for advanced non-small cell lung cancer with epidermal growth factor receptor mutations: results of the West Japan Thoracic Oncology Group trial (WJTOG0403). Br J Cancer (2008) 2.19
MicroRNA-126 inhibits invasion in non-small cell lung carcinoma cell lines. Biochem Biophys Res Commun (2008) 2.15
Absence of p16INK4 protein is restricted to the subset of lung cancer lines that retains wildtype RB. Oncogene (1994) 2.04
Distribution of glutathione-cystine transhydrogenase activity in subcellular fractions of rat intestinal mucosa. Biochem J (1969) 2.02
Evidence for non-spliced SV40 RNA in undifferentiated murine teratocarcinoma stem cells. Nature (1979) 1.99
Clinical benefit of continuing ALK inhibition with crizotinib beyond initial disease progression in patients with advanced ALK-positive NSCLC. Ann Oncol (2014) 1.97
Transfer of a premature or other high-risk newborn infant to a referral hospital. Pediatr Clin North Am (1966) 1.94
Inhibition of T helper cell type 2 cell differentiation and immunoglobulin E response by ligand-activated Valpha14 natural killer T cells. J Exp Med (1999) 1.88
MRI and CSF studies in the early diagnosis of Alzheimer's disease. J Intern Med (2004) 1.77
Laser photovaporization of endometrium for the treatment of menorrhagia. Am J Obstet Gynecol (1981) 1.71
RNA associated with murine intracisternal type A particles codes for the main particle protein. J Virol (1978) 1.69
Narcotic addiction, pregnancy, and the newborn. Am J Dis Child (1978) 1.68
Cystinuria: biochemical evidence for three genetically distinct diseases. J Clin Invest (1966) 1.68
Differentiation as a requirement for simian virus 40 gene expression in F-9 embryonal carcinoma cells. Proc Natl Acad Sci U S A (1979) 1.67
Uridine diphosphoglucose content of human erythrocytes: assessment by conversion to uridine diphosphoglucuronate. J Pediatr (1993) 1.59
Thymus-derived lymphocytes: humoral and cellular reactions distinguished by hydrocortisone. Science (1972) 1.58
"Retroposon" insertion into the cellular oncogene c-myc in canine transmissible venereal tumor. Proc Natl Acad Sci U S A (1985) 1.56
Genome-wide gene expression profiles of the developing mouse hippocampus. Proc Natl Acad Sci U S A (2001) 1.55
Defective induction of antigen-reactive proliferating T cells in B cell-deprived mice. Eur J Immunol (1981) 1.49
Clock gene dysfunction in patients with obstructive sleep apnoea syndrome. Eur Respir J (2008) 1.49
5' CpG island methylation of the FHIT gene is correlated with loss of gene expression in lung and breast cancer. Cancer Res (2001) 1.46
DNA methyltransferase inhibition enhances apoptosis induced by histone deacetylase inhibitors. Cancer Res (2001) 1.45
L-myc cooperates with ras to transform primary rat embryo fibroblasts. Mol Cell Biol (1988) 1.43
Rb and p16INK4a expression in resected non-small cell lung tumors. Cancer Res (1996) 1.41
Synchronous intrauterine and tubal pregnancies with subchorionic hematoma. Acta Obstet Gynecol Scand (1993) 1.40
Tumor characteristics in African American and white women. Breast Cancer Res Treat (2001) 1.39
Neonatal intensive care. A prediction of continuing development. Pediatr Clin North Am (1966) 1.39
Human breast cancer specimens: diffraction-enhanced imaging with histologic correlation--improved conspicuity of lesion detail compared with digital radiography. Radiology (2000) 1.39
Characteristics of gamma-glutamyltranspeptidase in cultured skin fibroblasts from normals and cystinotics. Enzyme (1981) 1.38
Alternative medicine use in presurgical patients. Anesthesiology (2000) 1.37
Differential expression of H-2 gene products in tumour cells in associated with their metastatogenic properties. Nature (1980) 1.35
Anesthetic drugs accelerate the progression of postoperative metastases of mouse tumors. J Clin Invest (1981) 1.34
Tuftsin (an Ig-associated tetrapeptide) triggers the immunogenic function of macrophages: implications for activation of programmed cells. Proc Natl Acad Sci U S A (1978) 1.33
RNA sequences specifically associated with mouse intracisternal A particles. Cell (1977) 1.33
Altered LKB1/CREB-regulated transcription co-activator (CRTC) signaling axis promotes esophageal cancer cell migration and invasion. Oncogene (2011) 1.32
Atrophy rate in medial temporal lobe during progression of Alzheimer disease. Neurology (2004) 1.31
Loss of p16(INK4a) expression correlates with decreased survival in pediatric osteosarcomas. Int J Cancer (2001) 1.30
Increased expression of unmethylated CDKN2D by 5-aza-2'-deoxycytidine in human lung cancer cells. Oncogene (2001) 1.30
Endogenous synthesis of galactose in normal men and patients with hereditary galactosaemia. Lancet (1995) 1.27
Intellectual outcome in children with maple syrup urine disease. J Pediatr (1991) 1.26
Thin-layer chromatographic separation of cystine and the N-ethylmaleimide adducts of cysteine and glutathionen. Anal Biochem (1969) 1.24
Incomplete penetrance of familial retinoblastoma linked to germ-line mutations that result in partial loss of RB function. Proc Natl Acad Sci U S A (1997) 1.21
MHC imbalance and metastatic spread in Lewis lung carcinoma clones. Int J Cancer (1983) 1.21
Hyperacusis: review and clinical guidelines. Otol Neurotol (2001) 1.20
A mouse model of galactose-1-phosphate uridyl transferase deficiency. Biochem Mol Med (1996) 1.19
The need for epidemiologic studies of in-situ carcinoma of the breast. Breast Cancer Res Treat (1995) 1.18
A common renal transport system for lysine, ornithine, arginine and cysteine. Biochem Biophys Res Commun (1966) 1.17
ADAM family proteins in the immune system. Immunol Today (1999) 1.17
Upregulation of VEGF-A and CD24 gene expression by the tGLI1 transcription factor contributes to the aggressive behavior of breast cancer cells. Oncogene (2011) 1.17
Chromatin-positive Klinefelter's syndrome with undetectable peripheral FSH levels. Am J Med (1975) 1.16
Sex-associated differences in the regulation of immune responses controlled by the MHC of the mouse. J Immunol (1984) 1.16
Developmental aspects and some characteristics of mammalian galactose 1-phosphate uridyltransferase. J Biol Chem (1966) 1.16
Sustained expression of Mect1-Maml2 is essential for tumor cell growth in salivary gland cancers carrying the t(11;19) translocation. Oncogene (2006) 1.15
The N-terminal domain of c-Myc associates with alpha-tubulin and microtubules in vivo and in vitro. Mol Cell Biol (1995) 1.14
Expression of a TGF-beta1 inducible gene, TSC-36, causes growth inhibition in human lung cancer cell lines. Cancer Lett (2000) 1.14
Longitudinal cerebrospinal fluid tau load increases in mild cognitive impairment. Neurosci Lett (2002) 1.14
Global methylation profiling of lung cancer identifies novel methylated genes. Neoplasia (2001) 1.14
In vivo evidence of brain galactitol accumulation in an infant with galactosemia and encephalopathy. J Pediatr (2001) 1.14
Loss of KAI1 expression in the progression of colorectal cancer. Cancer Res (1999) 1.13
Loss of p16/CDKN2A tumor suppressor protein in gastric adenocarcinoma is associated with Epstein-Barr virus and anatomic location in the body of the stomach. Hum Pathol (2000) 1.13
Relationship between vascular endothelial growth factor and interleukin-6 in diabetic retinopathy. Retina (2001) 1.12
RB protein status and clinical correlation from 171 cell lines representing lung cancer, extrapulmonary small cell carcinoma, and mesothelioma. Oncogene (1994) 1.12
Dibasic amino acid transport in rat-kidney cortex slices. Biochim Biophys Acta (1967) 1.12
Partial inactivation of the RB product in a family with incomplete penetrance of familial retinoblastoma and benign retinal tumors. Oncogene (1994) 1.12
Proline and glycine uptake by renal brushborder membrane vesicles. Proc Natl Acad Sci U S A (1976) 1.12